NCT02773953

Brief Summary

Improvement in CPAP adherence can be obtained by usingTelemonitoring. T4P® is a telemonitoring unit added on CPAP device allowing to obtain a daily report of usage duration, mask leaks, pressure and apnea-hypopnea index. The purpose of this study is to assess the impact of telemonitoring on the delay to the first technical intervention after CPAP titration night in CPAP-treated obstructive sleep apnea patients managed in the sleep unit. The shortening of this delay could help to improve adherence during the first weeks of treatment. As a secondary aim, the investigators would like to assess the impact of telemonitoring on mean adherence during the first 3 months of treatment, which is a crucial period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

April 25, 2016

Completed
21 days until next milestone

First Posted

Study publicly available on registry

May 16, 2016

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

April 26, 2017

Status Verified

October 1, 2016

Enrollment Period

8 months

First QC Date

April 25, 2016

Last Update Submit

April 25, 2017

Conditions

Keywords

CPAPTelemonitoring

Outcome Measures

Primary Outcomes (1)

  • Intervention delay (days)

    Delay between CPAP titration night and first intervention (phone call/visit)

    3 months

Secondary Outcomes (1)

  • Adherence to treatment

    3 months

Study Arms (2)

CPAP + T4PTelemonitoring device

EXPERIMENTAL

T4P® (Telemonitoring device) is added to CPAP at home. Sleep lab technical staff are connecting to the web portal 2 X/ week. In case of air leaks, persistant significant apnea-hypopnea index, use \< 3h on three consecutive days, they have to call the patient .

Device: T4PTelemonitoringDevice: CPAP

CPAP standard care

ACTIVE COMPARATOR

After CPAP titration night, patients are instructed to use the device each night for the whole night. They receive written instruction and can reach the sleep unit (phone call, visit) how often they need, during week days, to resolve CPAP-related problems. A group educational session is scheduled 1 month after and a visit to the pneumologist 1.5 months after.

Device: CPAP

Interventions

addition of a Telemonitoring unit on the CPAP line to standard care.

CPAP + T4PTelemonitoring device
CPAPDEVICE

CPAP treatment for treatment of obstructive sleep apnea syndrome

CPAP + T4PTelemonitoring deviceCPAP standard care

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with obstructive sleep apnea syndrome and AHI \> 20/h, who start treatment with CPAP.

You may not qualify if:

  • Patients already on treatment with CPAP.
  • Patients leaving Belgium for more than 3 weeks during study period.
  • Severe restrictive respiratory disorders.
  • Severe respiratory or cardiac disease.
  • Severe psychiatric disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU st Pierre-sleep lab

Brussels, 1000, Belgium

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Officials

  • Marie Bruyneel, MD, Phd

    CHU St. Pierre, Brussels

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2016

First Posted

May 16, 2016

Study Start

April 1, 2016

Primary Completion

December 1, 2016

Study Completion

March 1, 2017

Last Updated

April 26, 2017

Record last verified: 2016-10

Data Sharing

IPD Sharing
Will not share

Locations